The US Food and Drug Administration approved Augtyro in 2023 for the treatment of ROS1-positive advanced NSCLC. Earlier this year, the FDA also approved the drug for adult and pediatric patients 12 ...
With force persistence and stain resistance, 3M Clarity Aligners are set to contribute to patient comfort and aesthetic ...
Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback